← Evidence map

ReviewNature reviews. Neurology2021

Aducanumab and the FDA - where are we now?

Howard Fillit et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

47 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33442064